A detailed history of Redmile Group, LLC transactions in Prime Medicine, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 2,074,350 shares of PRME stock, worth $6.64 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
2,074,350
Previous 2,074,350 -0.0%
Holding current value
$6.64 Million
Previous $10.7 Million 24.71%
% of portfolio
0.52%
Previous 0.7%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$6.35 - $9.39 $4.76 Million - $7.04 Million
750,000 Added 56.63%
2,074,350 $14.5 Million
Q2 2023

Aug 14, 2023

SELL
$11.41 - $17.05 $7.63 Million - $11.4 Million
-668,493 Reduced 33.54%
1,324,350 $19.4 Million
Q1 2023

May 15, 2023

SELL
$11.21 - $21.11 $2.43 Million - $4.57 Million
-216,507 Reduced 9.8%
1,992,843 $24.5 Million
Q4 2022

Feb 14, 2023

BUY
$15.2 - $21.12 $33.6 Million - $46.7 Million
2,209,350 New
2,209,350 $41 Million

Others Institutions Holding PRME

About Prime Medicine, Inc.


  • Ticker PRME
  • Shares Outstandng 95,730,200
  • Market Cap $306M
More about PRME
Track This Portfolio

Track Redmile Group, LLC Portfolio

Follow Redmile Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Redmile Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Redmile Group, LLC with notifications on news.